/
/
/

Venmax Drugs And Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)14.99
Volume (₹)12,033.00
High (₹)15.30
Upper Circuit16.94
Low (₹)13.60
Lower Circuit11.30
Prev Close14.12
52W High (₹)31.49
Price15.30
52W Low (₹)13.52

Share Market Cap & Key Ratios Overview

M.Cap (₹)20.45 Cr
Div. Yield (%)0.00
PE Ratio72.78
Debt to Equity-0.08
Price to Book-22.62
Book Value-1.26
EPS (TTM)0.19
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
VENMAX-XNSE
LTP
1W Low
1W High
Market cap (₹)
1902.95-17.15 (-0.89%)
1896.30
1964.85
4,56,833Cr
9149-120 (-1.29%)
9051.85
9296
2,45,426Cr
4833.7-201.3 (-4.00%)
4822.25
5049
1,87,320Cr
1125.95-61.05 (-5.14%)
1125.30
1191.45
1,13,217Cr
1380-38 (-2.68%)
1376
1426.20
1,12,212Cr
1844.25-91.05 (-4.70%)
1812
1947.90
1,01,155Cr
2107.3-67.7 (-3.11%)
2107.30
2209
97,626Cr
2331.8-55.6 (-2.33%)
2323.15
2407.40
96,859Cr
1157-20.8 (-1.77%)
1155
1179.90
96,406Cr
1658.95+8.95 (0.54%)
1623.05
1706.70
93,614Cr
15.3-0.68 (-4.26%)
13.52
15.90
20Cr

Key Highlights of Venmax Drugs And Pharmaceuticals Ltd Balance Sheet

Venmax Drugs And Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹5.24Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹5.24Cr, and the reserves and surplus of the company is -₹5.9Cr.

The company has its non-current liabilities with total liabilities of ₹5.17Cr as of 2025-03-31.

The current liabilities are ₹75.67Lakh as of 2025-03-31. At the same time, current assets are ₹5.13Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of 0 and tangible assets of ₹4.05Lakh, provided in the Venmax Drugs And Pharmaceuticals Ltd financial statements.